Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2019 Filed Jun 14, 2019 21:22 UTC |
Bernard Gordon RDirector
|
SaleCommon Stock | 663 | $6.46 | $4,282.98 |
DisclosureSEC source: 0001209191-19-037202 · doc4.xml · nonDerivative · entry 3 Bernard Gordon R · CIK 0001470015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,477 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. This plan was established due to the policy change at Vanderbilt Medical Center requiring that senior executives divest holdings in biopharmaceutical companies. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.68 to $5.86, inclusive. The reporting person undertakes to provide to Cumberland Pharmaceuticals Inc., any security holder of Cumberland Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.50 to $6.43, inclusive. Read SEC document |
| May 30, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.58 | $394.80 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 21 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,028 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 29, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 65 | $6.52 | $423.80 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 20 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,227 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 29, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 60 | $6.53 | $391.80 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,892 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 29, 2019 Filed Jun 14, 2019 21:22 UTC |
Bernard Gordon RDirector
|
SaleCommon Stock | 1,800 | $6.38 | $11,484.00 |
DisclosureSEC source: 0001209191-19-037202 · doc4.xml · nonDerivative · entry 2 Bernard Gordon R · CIK 0001470015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,140 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. This plan was established due to the policy change at Vanderbilt Medical Center requiring that senior executives divest holdings in biopharmaceutical companies. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.68 to $5.86, inclusive. The reporting person undertakes to provide to Cumberland Pharmaceuticals Inc., any security holder of Cumberland Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.40 to $6.33, inclusive. Read SEC document |
| May 29, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.53 | $391.80 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 20 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,968 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 29, 2019 Filed Jul 12, 2019 21:17 UTC |
Young CarolineDirector
|
PurchaseCommon Stock | 50 | $6.43 | $321.50 |
DisclosureSEC source: 0001209191-19-041963 · doc4.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,839 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 28, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 65 | $6.64 | $431.60 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 19 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,162 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 28, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 60 | $6.65 | $399.00 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,832 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 28, 2019 Filed Jun 14, 2019 21:22 UTC |
Bernard Gordon RDirector
|
SaleCommon Stock | 3,789 | $6.44 | $24,401.16 |
DisclosureSEC source: 0001209191-19-037202 · doc4.xml · nonDerivative · entry 1 Bernard Gordon R · CIK 0001470015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,940 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. This plan was established due to the policy change at Vanderbilt Medical Center requiring that senior executives divest holdings in biopharmaceutical companies. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.68 to $5.86, inclusive. The reporting person undertakes to provide to Cumberland Pharmaceuticals Inc., any security holder of Cumberland Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.26, inclusive. Read SEC document |
| May 28, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.65 | $399.00 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 19 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,908 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 24, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 65 | $6.66 | $432.90 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 18 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,097 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 24, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 60 | $6.67 | $400.20 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,772 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 24, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.67 | $400.20 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 18 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,848 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 24, 2019 Filed Jul 12, 2019 21:17 UTC |
Young CarolineDirector
|
PurchaseCommon Stock | 75 | $6.48 | $486.00 |
DisclosureSEC source: 0001209191-19-041963 · doc4.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,789 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 23, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 850 | $6.44 | $5,474.00 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 10 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,415 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 23, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 65 | $6.52 | $423.80 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 17 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,032 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 23, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 60 | $6.53 | $391.80 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,712 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 23, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.53 | $391.80 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 17 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,788 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 22, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 850 | $6.49 | $5,516.50 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 9 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,565 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 22, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 65 | $6.57 | $427.05 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 16 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,967 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 22, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 60 | $6.58 | $394.80 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,652 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 22, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.58 | $394.80 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 16 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,728 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 21, 2019 Filed May 31, 2019 21:13 UTC |
Pavliv LeoSVP and Chief Development Off.
|
Tax withholdingCommon Stock | 1,850 | $6.30 | $11,655.00 |
DisclosureSEC source: 0001209191-19-033697 · doc4.xml · nonDerivative · entry 1 Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,611 F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. Read SEC document |
| May 21, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 850 | $6.49 | $5,516.50 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 8 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,715 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 21, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 65 | $6.70 | $435.50 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 15 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,902 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 21, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 60 | $6.71 | $402.60 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,592 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 21, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.71 | $402.60 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 15 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,668 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 21, 2019 Filed Jul 12, 2019 21:17 UTC |
Young CarolineDirector
|
PurchaseCommon Stock | 50 | $6.61 | $330.50 |
DisclosureSEC source: 0001209191-19-041963 · doc4.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,714 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 20, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 850 | $6.89 | $5,856.50 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 7 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,865 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 20, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 65 | $6.89 | $447.85 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 14 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,837 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 20, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 60 | $6.89 | $413.40 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,532 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 20, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 60 | $6.89 | $413.40 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 14 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,608 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 17, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 794 | $6.20 | $4,922.80 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 6 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,015 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 17, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 148 | $6.19 | $916.12 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,772 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 17, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 106 | $6.25 | $662.50 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,472 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 17, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 106 | $6.25 | $662.50 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 13 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,548 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 17, 2019 Filed Jul 12, 2019 21:17 UTC |
Young CarolineDirector
|
PurchaseCommon Stock | 44 | $6.19 | $272.36 |
DisclosureSEC source: 0001209191-19-041963 · doc4.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,664 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 16, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 301 | $5.99 | $1,802.99 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 5 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,221 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 15, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 677 | $6.00 | $4,062.00 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 4 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,920 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 15, 2019 Filed Jul 12, 2019 21:17 UTC |
Young CarolineDirector
|
PurchaseCommon Stock | 51 | $5.66 | $288.66 |
DisclosureSEC source: 0001209191-19-041963 · doc4.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,620 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 14, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 66 | $5.48 | $361.68 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 3 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,243 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 14, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 49 | $5.59 | $273.91 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,624 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 14, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 36 | $5.62 | $202.32 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,366 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 14, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 36 | $5.62 | $202.32 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 12 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,442 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 13, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 526 | $5.67 | $2,982.42 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 2 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,177 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 10, 2019 Filed May 31, 2019 21:12 UTC |
JACOBS JOEY ADirector
|
PurchaseCommon Stock | 931 | $5.92 | $5,511.52 |
DisclosureSEC source: 0001209191-19-033695 · doc4.xml · nonDerivative · entry 1 JACOBS JOEY A · CIK 0001243878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,651 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 10, 2019 Filed Jun 14, 2019 21:22 UTC |
Krogulski KennethDirector
|
PurchaseCommon Stock | 76 | $5.99 | $455.24 |
DisclosureSEC source: 0001209191-19-037204 · doc4.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,575 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 10, 2019 Filed Jun 14, 2019 21:21 UTC |
KAZIMI A JDirector · Chairman and CEO · 10% owner
|
PurchaseCommon Stock | 57 | $6.01 | $342.57 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,330 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| May 10, 2019 Filed Jun 14, 2019 21:20 UTC |
Galante Joseph CDirector
|
PurchaseCommon Stock | 57 | $6.01 | $342.57 |
DisclosureSEC source: 0001209191-19-037200 · doc4.xml · nonDerivative · entry 11 Galante Joseph C · CIK 0001632384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,406 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.